No Yes Ok

Archive

« Older Entries Newer Entries »

Probiodrug reports First Quarter 2015 Business Update Wednesday, May 13th, 2015
HALLE/SAALE, Germany, 13 May 2015 – Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer’s disease (AD), today announces its first quarter [...]
Affimed N.V. Announces Closing of Public Offering of Common Stock and Exercise of Underwriters' Option to Purchase Additional Shares Wednesday, May 13th, 2015
Heidelberg, Germany, May 12, 2015 - Affimed N.V. (Nasdaq: AFMD), a clinical-stage biopharmaceutical company developing highly targeted cancer immunotherapies, today announced the closing of its previously announced pu [...]
PMV and LSP enter into strategic partnership in life sciences Monday, May 11th, 2015
PMV and LSP enter into strategic partnership in life sciences   Brussels, Belgium and Amsterdam, The Netherlands – May 11th 2015   ParticipatieMaatschappij Vlaanderen (PMV) and Life Sciences Partne [...]
Curetis Strengthens Executive Team; Appoints Dr. Achim Plum as Chief Commercial Officer Monday, May 11th, 2015
• Former Siemens Healthcare manager adds broad expertise in molecular diagnostics, sales, marketing, and business development    Holzgerlingen, Germany, May 11, 2015 -- Curetis AG, a developer of next-leve [...]
Affimed N.V. Announces Pricing of Public Offering of Common Stock Wednesday, May 6th, 2015
Heidelberg, Germany, May 6, 2015 - Affimed N.V. (Nasdaq: AFMD), a clinical-stage biopharmaceutical company developing highly targeted cancer immunotherapies, today announced the pricing of its previously announced pub [...]
Setting the new standard in decentralised molecular diagnostics Monday, May 4th, 2015
Bath, UK, 1 May 2015. Atlas Genetics Ltd (“Atlas” or the “Company”), developer of innovative, ultra-rapid diagnostics to enable a ‘test and treat’ solution to infectious diseases, today announces its Annua [...]
Hybrigenics full year 2014 results Tuesday, April 28th, 2015
Strong cash position further recently increased by EUR 9 million   Paris, 27 April 2015 – Hybrigenics SA (ALHYG), a bio-pharmaceutical group listed on the Alternext market of Euronext in Paris, with a focus o [...]
LSP portfolio company Agenus in the press Tuesday, April 28th, 2015
Please find two links to press releases issued this week by Agenus www.agenusbio.com. One (press release can be found here) announces the positive clinical testing of a malaria vaccine by GSK containing the proprietar [...]
arGEN-X Announces Publication on Therapeutic Potential of Antibody ARGX-115 in Cancer Immunotherapy Thursday, April 23rd, 2015
Results on ARGX-115 published in Science Translational Medicine indicating inhibition of immune checkpoint GARP in in vivo mouse model.   Breda, The Netherlands / Ghent, Belgium, April 23, 2015 - arGEN-X N.V. [...]
Exciting stuff at the BioCapital Europe 2015 Conference Monday, April 20th, 2015
March 26, LSP organized the BioCapital Europe Conference for the 13th consecutive time. The prestigious hotel The Grand in Amsterdam set the stage for one of the premier life sciences events in Europe. During the day, [...]

« Older Entries Newer Entries »

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
back to archive overview
Follow us

No Yes Ok

Archive

« Older Entries Newer Entries »

Probiodrug reports First Quarter 2015 Business Update Wednesday, May 13th, 2015
HALLE/SAALE, Germany, 13 May 2015 – Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer’s disease (AD), today announces its first quarter [...]
Affimed N.V. Announces Closing of Public Offering of Common Stock and Exercise of Underwriters' Option to Purchase Additional Shares Wednesday, May 13th, 2015
Heidelberg, Germany, May 12, 2015 - Affimed N.V. (Nasdaq: AFMD), a clinical-stage biopharmaceutical company developing highly targeted cancer immunotherapies, today announced the closing of its previously announced pu [...]
PMV and LSP enter into strategic partnership in life sciences Monday, May 11th, 2015
PMV and LSP enter into strategic partnership in life sciences   Brussels, Belgium and Amsterdam, The Netherlands – May 11th 2015   ParticipatieMaatschappij Vlaanderen (PMV) and Life Sciences Partne [...]
Curetis Strengthens Executive Team; Appoints Dr. Achim Plum as Chief Commercial Officer Monday, May 11th, 2015
• Former Siemens Healthcare manager adds broad expertise in molecular diagnostics, sales, marketing, and business development    Holzgerlingen, Germany, May 11, 2015 -- Curetis AG, a developer of next-leve [...]
Affimed N.V. Announces Pricing of Public Offering of Common Stock Wednesday, May 6th, 2015
Heidelberg, Germany, May 6, 2015 - Affimed N.V. (Nasdaq: AFMD), a clinical-stage biopharmaceutical company developing highly targeted cancer immunotherapies, today announced the pricing of its previously announced pub [...]
Setting the new standard in decentralised molecular diagnostics Monday, May 4th, 2015
Bath, UK, 1 May 2015. Atlas Genetics Ltd (“Atlas” or the “Company”), developer of innovative, ultra-rapid diagnostics to enable a ‘test and treat’ solution to infectious diseases, today announces its Annua [...]
Hybrigenics full year 2014 results Tuesday, April 28th, 2015
Strong cash position further recently increased by EUR 9 million   Paris, 27 April 2015 – Hybrigenics SA (ALHYG), a bio-pharmaceutical group listed on the Alternext market of Euronext in Paris, with a focus o [...]
LSP portfolio company Agenus in the press Tuesday, April 28th, 2015
Please find two links to press releases issued this week by Agenus www.agenusbio.com. One (press release can be found here) announces the positive clinical testing of a malaria vaccine by GSK containing the proprietar [...]
arGEN-X Announces Publication on Therapeutic Potential of Antibody ARGX-115 in Cancer Immunotherapy Thursday, April 23rd, 2015
Results on ARGX-115 published in Science Translational Medicine indicating inhibition of immune checkpoint GARP in in vivo mouse model.   Breda, The Netherlands / Ghent, Belgium, April 23, 2015 - arGEN-X N.V. [...]
Exciting stuff at the BioCapital Europe 2015 Conference Monday, April 20th, 2015
March 26, LSP organized the BioCapital Europe Conference for the 13th consecutive time. The prestigious hotel The Grand in Amsterdam set the stage for one of the premier life sciences events in Europe. During the day, [...]

« Older Entries Newer Entries »

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
back to archive overview
X

MONTHLY REPORTS

Here you can subscribe for the monthly report of the LSP Life Sciences Fund